Coherus Oncology, Inc.

CHRS · Nasdaq · SIC 2836: Biological Products, (No Diagnostic Substances)
280
SEC Filings

Business Summary

PARTI Overview We are a fully integrated commercial-stage innovative oncology company with an approved next-generation programmed death receptor-1 (PD-1) inhibitor, LOQTORZI (toripalimab-tpzi), and a pipeline that includes two mid-stage clinical candidates targeting liver, head and neck, colorectal and other cancers. Our strategy is to grow sales of LOQTORZI in nasopharyngeal carcinoma (NPC) and advance the development of new indications for LOQTORZI in combination with both our pipeline candida...

Next Earnings

Q2 FY2026 — expected 2026-09-05

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionCHRSdiscussed_in_filing Cybersecurity
topic_mentionCHRSdiscussed_in_filing Trusted Computing
topic_mentionCHRSdiscussed_in_filing Blockchain & Crypto
topic_mentionCHRSdiscussed_in_filing Regulation
topic_mentionCHRSdiscussed_in_filing Healthcare & Bio
topic_mentionCHRSdiscussed_in_filing Platform & Ecosystem
topic_mentionCHRSdiscussed_in_filing Sovereign & Government
topic_mentionCHRSdiscussed_in_filing Cybersecurity
topic_mentionCHRSdiscussed_in_filing Trusted Computing
topic_mentionCHRSdiscussed_in_filing Blockchain & Crypto
topic_mentionCHRSdiscussed_in_filing Regulation
topic_mentionCHRSdiscussed_in_filing Healthcare & Bio
topic_mentionCHRSdiscussed_in_filing Platform & Ecosystem
topic_mentionCHRSdiscussed_in_filing Sovereign & Government
topic_mentionCHRSdiscussed_in_filing Cybersecurity
topic_mentionCHRSdiscussed_in_filing Trusted Computing
topic_mentionCHRSdiscussed_in_filing Blockchain & Crypto
topic_mentionCHRSdiscussed_in_filing Regulation
topic_mentionCHRSdiscussed_in_filing Healthcare & Bio
topic_mentionCHRSdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-092025-12-310001104659-26-025308EDGAR91K words
2025-03-172024-12-310001558370-25-003126EDGAR—
2024-03-152023-12-310001558370-24-003436EDGAR—
2023-03-062022-12-310001558370-23-002917EDGAR—
2022-02-232021-12-310001558370-22-001764EDGAR—
2021-02-252020-12-310001558370-21-001829EDGAR—
2020-02-272019-12-310001564590-20-007416EDGAR—
2019-02-282018-12-310001564590-19-005470EDGAR—
2018-03-082017-12-310001564590-18-004947EDGAR—
2017-03-142016-12-310001564590-17-004176EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-062025-09-300001104659-25-107852EDGAR60K words
2025-08-072025-06-300001558370-25-010803EDGAR—
2025-05-122025-03-310001558370-25-007418EDGAR—
2024-11-062024-09-300001558370-24-014648EDGAR—
2024-08-082024-06-300001558370-24-011629EDGAR—
2024-05-092024-03-310001558370-24-007641EDGAR—
2023-11-062023-09-300001558370-23-017779EDGAR—
2023-08-022023-06-300001558370-23-012915EDGAR—
2023-05-082023-03-310001558370-23-008529EDGAR—
2022-11-082022-09-300001558370-22-016850EDGAR—
2022-08-042022-06-300001558370-22-012251EDGAR—
2022-05-052022-03-310001558370-22-007420EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-090001104659-26-025293EDGAR5K words
2026-02-170001104659-26-016378EDGAR—
2026-02-040001104659-26-010065EDGAR—
2026-01-230001104659-26-006307EDGAR—
2026-01-130001104659-26-003117EDGAR—
2025-11-130001104659-25-111484EDGAR—
2025-11-060001104659-25-107780EDGAR—
2025-09-080001558370-25-011911EDGAR—
2025-08-070001558370-25-010802EDGAR—
2025-07-030001558370-25-009085EDGAR—

280 total filings indexed. 248 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

FDMT — 4D Molecular Therapeutics, Inc. APTN — ADAPTIN BIO, INC. ADMA — ADMA BIOLOGICS, INC. AGEN — AGENUS INC AIM — AIM ImmunoTech Inc. AMGN — AMGEN INC AVXL — ANAVEX LIFE SCIENCES CORP. ABPO — Abpro Holdings, Inc.

Company Identity

CIK0001512762
TickerCHRS
ExchangeNasdaq
SIC2836: Biological Products, (No Diagnostic Substances)
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fc5f3273ec154f80c6aede5789f394692d4047e3d8666482fae713a7183c830f
parent: cd52cda642292f6ef1f9c4d879560105b76849d172eca0e125486b84375e6b53
content hash: 86f300425d0745531567726c82ffc208cd1868aaa0ae0691a411d933ffab0d0a
signed: 2026-04-13T04:44:19.184Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf